创新药东风浩荡:科创板未盈利IPO重新开闸

药智网
Aug 04

7月31日深夜,上交所网站悄然更新的一则信息在资本圈激起涟漪——珠海泰诺麦博制药股份有限公司(以下简称“泰诺麦博”),以科创板第五套标准递交的招股书获正式受理。这家专注于血液制品替代疗法的创新生物制药企业,成为科创板第五套标准宣布重启后,首家以此标准申请上市获得受理的企业。对此,中信证券医药首席分析师陈竹指出:从今年3月证监会党委会议指出稳妥恢复科创板第五套标准适用,到此刻,科创板第五套标准在暂停...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10